Andrew Trask litigates disputes involving intellectual property, competition, and technology.  He has represented clients in the U.S. district courts, on appeal, in inter partes review proceedings, and in commercial arbitrations.  With a doctorate in physical chemistry, work experience in Silicon Valley, and a handful of patents to his name, Andrew enjoys learning complex subjects and simplifying them for lay audiences.  His cases have involved pharmaceutical and biotech products, mobile apps and hardware, search and video algorithms, wearable devices, and medical technologies.

Appeals are a focus of Andrew’s practice.  He has briefed and argued several cases before the U.S. Court of Appeals for the Federal Circuit.  In 2021, Andrew joined the Federal Circuit Bar Association’s Board of Directors, and he previously served as the Chair of the FCBA Rules Committee. Andrew also co-teaches the Federal Circuit Practice seminar as an Adjunct Professor at George Mason University School of Law.

Andrew has handled several appeals pro bono before the U.S. Court of Appeals for Veterans Claims, helping military veterans obtain benefits for service-related medical disabilities.  He also serves as a Board member of CulinaryCorps, America’s first service-related nonprofit organization for culinary professionals.

Andrew joined the firm following a clerkship with the Honorable Alan D. Lourie of the Federal Circuit.  He left the firm to serve as in-house litigation counsel at a major technology company, then returned and joined the firm’s partnership in 2021.  The first lawyer in his family, Andrew attended Fordham Law School as an evening student.  He graduated magna cum laude as a member of the Order of the Coif and an Associate Editor of the Fordham Law Review, while working full-time prosecuting patent applications involving pharmaceutical and biotech inventions.  Prior to law school, Andrew worked as a pharmaceutical scientist and earned his Ph.D. from the University of Cambridge.


  • Patent Litigation Is Not Just for Scientists, BLOOMBERG LAW INSIGHTS (2021) (co-author).
  • Professional Civility Is Essential in the Pandemic, BLOOMBERG LAW INSIGHTS (2020) (co-author).
  • Conditional Cross-Appeals at the Federal Circuit, 22 FED. CIR. B.J. 501 (2013).
  • “Obvious to Try”: A Proper Patentability Standard in the Pharmaceutical Arts?, 76 FORDHAM L. REV. 2625 (2008).
  • An Overview of Pharmaceutical Cocrystals as Intellectual Property, 4 MOLECULAR PHARMACEUTICS 301 (2007).
  • Pharmaceutical Cocrystals: A Molecular Materials Approach to Physical Property Enhancement, 31 MRS BULL. 875 (2006) (co-author).
  • Solid-State Acid-Base Interactions in Complexes of Heterocyclic Bases and Dicarboxylic Acids, 128 J. AM. CHEMICAL SOC’Y, 8199 (2006) (co-author).
  • Screening for Inclusion Compounds and Systematic Construction of Three-Component Solids via Liquid-Assisted Grinding, 45 ANGEWANDTE CHEMIE INT’L EDITION 7546 (2006) (co-author).
  • Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration, 5 CRYSTAL GROWTH DESIGN 1013 (2005) (co-author).
  • Solvent-Drop Grinding: Green Polymorph Control of Cocrystallisation, CHEMICAL COMM. 890 (2004) (co-author).




“Leading Patent Litigation Attorney,” IAM Patent 1000, 2023

"Next Generation Lawyer," in the category of Intellectual Property: Patents: Litigation, The Legal 500, 2021


back to top